Bill Detail
S. 5571
Congress: 119
Title
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Sen. Marsha Blackburn [R-TN]
Status
Read twice and referred to the Committee on Finance.
Introduced
2026-09-28
Data source mode: congress-gov
Bill Engagement
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Sponsor
Sen. Marsha Blackburn [R-TN]R
Status
Read twice and referred to the Committee on Finance.
Cosponsors
1D · 2R
Bipartisan
LDA engagement
No active filings
Introduced
2026-09-28